Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine with Radiation and Temozolomide in Glioblastoma
NCT00486603Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Oct 2007
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in glioblastoma multiforme (GBM), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Oct 2007; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00486603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486603.